Are you a new member? Sign up now
Login area
| Sign up
close
PROLIA - 60mg/ml - 1
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M05BX04 | BioTech | Denosumab - 60mg/ml | 8921/388 | 163716/1 | PROLIA | 60mg/ml | 1 | Injectable solution | SC | Mersaco | Amgen Europe BV | The Netherlands | L.L | 19.35 | D | Amgen Europe BV | The Netherlands | 6/3/2026 |
Drugs With Same Ingredients
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M05BX04 | BioTech | Denosumab - 60mg/ml | 12597 | 56726/1 | JUBBONTI | 60mg/ml | 1 | Injectable solution | SC | Khalil Fattal & Fils S.A.L. | Novartis Pharmaceutical Manufacturing GmbH | Austria | 12,742,790 L.L | 21.26 | C | Sandoz GmbH | Austria | 6/3/2026 | |
| M05BX04 | BioTech | Denosumab - 60mg/ml | 8921 | 163716/1 | PROLIA | 60mg/ml | 1 | Injectable solution | SC | Mersaco | Amgen Europe BV | The Netherlands | 21,603,638 L.L | 19.35 | D | Amgen Europe BV | The Netherlands | 6/3/2026 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2026